about
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the revers...
Read More
4.28
-0.25
(-5.52%)
67,517.9
XNAS Volume
XNAS 18 Mar, 2026 3:21 PM (EDT)
Board Meeting
The next board meeting for CervoMed Inc is on 23 Mar 2026 for the purpose of 8(th) Annual ROTH Conference
See details
Not Eligible
Expensive Valuation
Technically Bearish
CervoMed Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..